PD-L1 knockdown significantly decreases tumor volume in murine ovarian cancer, melanoma (27), murine medulloblastoma (28), and U87 glioma in nude mice (29), while PD-L1 overexpression promotes glioma development (29). This evidence concerns the gene CD274 and central nervous system cancer.